Activity 3. Speaking and writing
Writing: A short Report (Learning object: Business report). Once you have watched the videos and read the articles and by using the information you just learnt from activity 1. It is time to create a Short Report.
Executive Summary.
Universal multinational pharmaceutical (UP), a company that develops medical installed in Atlanta (Georgia) has developed three more of its products, one of these products for weight loss promises to provide excellent results, and another drug is made to treat River blindness with a very high investment to develop and help thousands of people from Africa. These products have no profit. Going through the current issue of his medicine for asthma that has worsened their overall image, and the medicine tests for heart disease PX200, UP must decide if true to its principles and improve its image, or focus on the economic dividends.
Findings.
Thanks to the research and development the drug for diabetes and Parkinson it has showned a major improvement in people affected by this disease. However, the drug treatment for asthma was withdrawn from the market for its harmful side effects toapatients. The company's image was heavily damaged and raised questions in the media.
The new drug development to river blindness to help people in Africa it’s a big chance to change and improve the image for the company, because the drug has a high probability to success. To develop this drug the company needs over 1000 million of dollars, but in other ways the company has no chance to benefit for this, the reason is because people that needs this medicine dont have the budget and have vey low income, and have not resources to pay for this, so UP is not a charity organization. The company needs to know how to develop this drug without economic risk while improving its image.
In a case of PX200, this drug shown more benefits than side effects, for instance; The majority of patients have receive lower blood pressure and less pain. Some people have only experienced breathing difficulties and other unpleasant effects.
In the case of weight loss products, the test made in animals showed that some of these animals got sick in early stage trials, however the product promises to generate big profits once it is launched.
Conclusions.
It is very important to restore the company image due to the negative input from the media , and this puts in risk the company future with him customers and consumers. So the company must reconsider to develop this drug without taking any profit, and maybe use the profits of other products for this. The company must be find the balance in his Ethical policy and the profits. In the three cases, the River Blindness is the most opportunity to change the global company image and recovery the confidence in customers and consumers.
Executive Summary.
Universal multinational pharmaceutical (UP), a company that develops medical installed in Atlanta (Georgia) has developed three more of its products, one of these products for weight loss promises to provide excellent results, and another drug is made to treat River blindness with a very high investment to develop and help thousands of people from Africa. These products have no profit. Going through the current issue of his medicine for asthma that has worsened their overall image, and the medicine tests for heart disease PX200, UP must decide if true to its principles and improve its image, or focus on the economic dividends.
Findings.
Thanks to the research and development the drug for diabetes and Parkinson it has showned a major improvement in people affected by this disease. However, the drug treatment for asthma was withdrawn from the market for its harmful side effects toapatients. The company's image was heavily damaged and raised questions in the media.
The new drug development to river blindness to help people in Africa it’s a big chance to change and improve the image for the company, because the drug has a high probability to success. To develop this drug the company needs over 1000 million of dollars, but in other ways the company has no chance to benefit for this, the reason is because people that needs this medicine dont have the budget and have vey low income, and have not resources to pay for this, so UP is not a charity organization. The company needs to know how to develop this drug without economic risk while improving its image.
In a case of PX200, this drug shown more benefits than side effects, for instance; The majority of patients have receive lower blood pressure and less pain. Some people have only experienced breathing difficulties and other unpleasant effects.
In the case of weight loss products, the test made in animals showed that some of these animals got sick in early stage trials, however the product promises to generate big profits once it is launched.
Conclusions.
It is very important to restore the company image due to the negative input from the media , and this puts in risk the company future with him customers and consumers. So the company must reconsider to develop this drug without taking any profit, and maybe use the profits of other products for this. The company must be find the balance in his Ethical policy and the profits. In the three cases, the River Blindness is the most opportunity to change the global company image and recovery the confidence in customers and consumers.
Activity 4. Project (Final stage)
- Once you have chosen either option 1 or 2 for your final face to face session presentation. You and your partners are going to work out the following aspects:
- Option 1: choose a Colombian company that exports any product to the United States or Canada.
- Option 2: choose an international company (English speaking country) that had introduced a product or a service in Colombia.
- Explain the CSR – Corporate Social Responsibility of the company in Colombia or in the foreign market the company is.
- What kind of programs and to whom are aim to these CSR programs.
- In the face to face session you and your group are going to show your group´s e-portfolio, explaining all the information you gathered about the company you have chosen for this project.
Suscribirse a:
Entradas (Atom)